News | ASTRO | October 24, 2020

ASTRO's Exhibit Hall Only Day Draws Over 1,000 Attendees

Conference programming for ASTRO20 began today, and runs through October 29

Conference programming for ASTRO20 began today, and runs through October 29 #ASTRO20

October 24, 2020 — The American Society of Radiation Oncology's (ASTRO) 62nd Annual Meeting launched its Exhibit Hall Only Day yesterday, a new event one day before programming begins, to provide more time for attendees to network and interact with exhibitors. More than 1,000 attendees from 60 countries participated in Exhibit Hall Only Day yesterday, visiting our more than 110 exhibitors.

Traci Conley, regional account manager with Standard Imaging, Inc. shared, “This is absolutely amazing! I stopped in the lounge this morning and it seems everyone shares the opinion…this is engaging and user-friendly. Well done to the entire ASTRO team!”

“This has been a great experience and exceeds my expectations and past experience of a virtual meeting,” said Kelly Graber, Stryker senior program manager-Tradeshow.

“This virtual Exhibit Hall is one of the best platforms I've experienced this year, and we're pleased with the amount of exposure and access it has given us. The ASTRO team always organizes a great event with quality scientific content mixed with vendor participation and social activities to provide everyone with an exceptional experience each year,” said Melanie Benton, director, Marketing, at Mevion Medical Systems.

ASTRO20 runs October 24-28, 2020, via an interactive virtual platform. The meeting, Global Oncology: Radiation Therapy in a Changing World, will feature reports from the latest clinical trials; panels on global oncology, health disparities and the novel coronavirus; and an immersive attendee experience in a virtual convention center.

Originally planned as an on-site meeting in Miami, the ASTRO 2020 Annual Meeting was moved to a web-based platform due to safety concerns associated with the COVID-19 pandemic. Given the large volume of new science to be unveiled, the content will be available for 30 days after the meeting ends.

"Cancer doesn’t wait, even during a pandemic. With the health and safety of cancer patients in mind, we chose to invest in an interactive platform so that we can offer attendees a complete meeting experience,” said ASTRO President Thomas J. Eichler, M.D., FASTRO. “Attendees will be able to engage with each other on live video and chat platforms and access more than 2,500 abstracts. We will have live, on-demand and interactive sessions to showcase the latest research and best practices in cancer treatment. Recognizing that many meetings were cancelled or abbreviated this year, we enhanced our educational program and will have more than 200 hours of continuing medical education (CME) credits available for 30 days after the meeting ends.”

The meeting platform includes a digital rendering of the Miami Beach Convention Center that attendees can navigate to interact with other attendees and ASTRO leadership, visit networking lounges, participate in job interviews and attend live and on-demand sessions.

For more information: ASTRO20

Related Content

During active surveillance, prostate cancer is carefully monitored for signs of progression through regular prostate-specific antigen (PSA) screening, prostate exams, imaging, and repeat biopsies.

Getty Images

News | Prostate Cancer | November 18, 2020
November 18, 2020 — ...
In partnership with Imaging Technology News, we collected feedback from more than 100 diagnostic imaging professionals including healthcare executives, radiology and IT leaders, radiologists, technologists, clinicians, and industry vendors regarding their perspective of the new virtual format, whether they’re attending, and if so what they’re hoping to get out of it. #RSNA20
Feature | Radiology Business | November 17, 2020 | By Laurie Lafleur
Shine Test System paired with the world’s strongest commercial fusion neutron generator manufactured by Phoenix. It can break apart low-enriched uranium to produce moly-99 for medical isotope production.

Shine Test System paired with the world’s strongest commercial fusion neutron generator manufactured by Phoenix. It can break apart low-enriched uranium to produce moly-99 for medical isotope production.

Feature | Nuclear Imaging | November 12, 2020 | By Willow Ascenzo
Medical imaging procedures such as single-photon emission computed tomography (...
Minimizing delays to treatment could improve cancer survival rates, say researchers

Getty Images

News | Radiation Oncology | November 10, 2020
November 10, 2020 — People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% high
Honoring essential healthcareprofessionals, Nov. 8-14
News | Radiology Imaging | November 09, 2020
November 9, 2020 — As COVID-19 continues to spre
In this retrospective cohort study of men with low-risk prostate cancer followed up for a median of 7.6 years, African American men, compared with non-Hispanic White men, had a statistically significant increased 10-year cumulative incidence of disease progression and definitive treatment, but not metastasis or prostate cancer–specific mortality

Getty Images

News | Prostate Cancer | November 04, 2020
November 4, 2020 — Previous studies have shown that African American men are 2.4 times as likely to die from...